Kodiak Sciences Inc Common Stock KOD
$89.92
+177.96%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $87.33
- Implied Upside
- -2.9%
- Price Target Range
- $36.00 – $145.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-28 | LifeSci CapitalPatrick Dolezal |
Maintains | Outperform | $85 → $145 |
| 2026-09-28 | UBSMichael Yee |
Maintains | Buy | $80 → $120 |
| 2026-09-28 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $58 → $96 |
| 2026-09-24 | Goldman SachsAndrea Newkirk |
Reinstates | Neutral | $36 |
| 2026-09-17 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $58 |
| 2026-08-17 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $58 |
| 2026-08-03 | JP MorganAnupam Rama |
Maintains | Overweight | $56 → $66 |
| 2026-05-11 | Chardan CapitalDaniil Gataulin |
Upgrades | Neutral → Buy | $14 → $61 |
| 2026-03-27 | UBSMichael Yee |
Maintains | Buy | $50 → $80 |
| 2026-03-27 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $38 → $58 |
| 2026-02-10 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $38 |
| 2026-01-22 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $26 → $38 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Buy | $50 |
| 2025-11-17 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $14 |
| 2025-11-17 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $24 → $26 |
| 2025-11-11 | HC Wainwright & Co.Matthew Caufield |
Upgrades | Neutral → Buy | $5 → $24 |
| 2025-10-24 | JP MorganAnupam Rama |
Upgrades | Neutral → Overweight | $15 → $24 |
| 2025-10-23 | LifeSci CapitalPatrick Dolezal |
Initiates coverage on | Outperform | $40 |
| 2025-10-06 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $14 |
| 2025-09-25 | BarclaysGena Wang |
Upgrades | Underweight → Equal-weight | $7 → $17 |
| 2025-09-22 | JefferiesMaury Raycroft |
Initiates coverage on | Buy | $15 |
| 2025-08-18 | HC Wainwright & Co.Matthew Caufield |
Maintains | Neutral | $3 → $5 |
| 2025-08-14 | BarclaysGena Wang |
Maintains | Underweight | $4 → $7 |
| 2025-08-14 | JP MorganAnupam Rama |
Upgrades | Underweight → Neutral | $15 |
| 2025-03-31 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-12-09 | JefferiesMichael Yee |
Upgrades | Hold → Buy | $20 |
| 2024-11-15 | BarclaysGena Wang |
Maintains | Underweight | $3 → $4 |
| 2024-11-15 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-09-24 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-09-05 | HC Wainwright & Co.Matthew Caufield |
Initiates coverage on | Neutral | $3 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $89.92
- Market Cap
- $2.03 billion
- 52-Week Range
- $8.29 – $95.77
- Average Volume
- 2.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.